Promoter Methylation and Increased Expression of PD-L1 in Patients with Active Tuberculosis

Overview

Journal Microb Cell

Specialty Microbiology

Date 2024 Jul 31

PMID 39081906

Authors

Yen-Han Tseng

Sheng-Wei Pan

Jhong-Ru Huang

Chang-Ching Lee

Jung-Jyh Hung

Po-Kuei Hsu

Nien-Jung Chen

Wei-Juin Su

Yuh-Min Chen

Jia-Yih Feng

Affiliations

Soon will be listed here.

Abstract

The PD-1/PD-L1 pathway plays a pivotal role in T cell activity and is involved in the pathophysiology of (MTB) infection. DNA methylation is a mechanism that modulates PD-L1 expression in cancer cells. However, its effect on PD-L1 expression in macrophages after MTB infection remains unknown. We prospectively enrolled patients with active tuberculosis (TB) and non-TB subjects. The expression of PD-L1 and methylation-related genes in peripheral blood mononuclear cells (PBMCs) were investigated and their correlation with disease severity and treatment outcomes were examined. PD-L1 promoter methylation status was evaluated using bisulfite sequencing. Immunohistochemistry (IHC) and immunofluorescence (IF) staining were used to visualize PD-L1- and TET-1-expressing cells in lung tissues from patients with TB and in macrophage cell lines with MTB-related stimulation. In total, 80 patients with active TB and 40 non-TB subjects were enrolled in the analysis. Patients with active TB had significantly higher expression of , , , , and lower expression of , compared to that in the non-TB subjects. The expression of and was significantly associated with 1-month smear and culture non-conversion. IHC and IF staining demonstrated the co-localization of PD-L1- and TET-1-expressing macrophages in patients with pulmonary TB and in human macrophage cell lines after MTB-related stimulation. DNMT inhibition and knockdown in human macrophages increased and decreased expression, respectively. Overall, expression is increased in patients with active TB and is correlated with treatment outcomes. DNA methylation is involved in modulating expression in human macrophages.

References

Barber D, Wherry E, Masopust D, Zhu B, Allison J, Sharpe A . Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2005; 439(7077):682-7. DOI: 10.1038/nature04444. View

Chandra P, Grigsby S, Philips J . Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022; 20(12):750-766. PMC: 9310001. DOI: 10.1038/s41579-022-00763-4. View

Zhai W, Wu F, Zhang Y, Fu Y, Liu Z . The Immune Escape Mechanisms of . Int J Mol Sci. 2019; 20(2). PMC: 6359177. DOI: 10.3390/ijms20020340. View

Qin W, Hu L, Zhang X, Jiang S, Li J, Zhang Z . The Diverse Function of PD-1/PD-L Pathway Beyond Cancer. Front Immunol. 2019; 10:2298. PMC: 6787287. DOI: 10.3389/fimmu.2019.02298. View

Suarez G, Melucci Ganzarain C, Vecchione M, Trifone C, Marin Franco J, Genoula M . PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8 T cell Induced Death. Sci Rep. 2019; 9(1):187. PMC: 6336852. DOI: 10.1038/s41598-018-36403-2. View

Du Y, Gao X, Yan J, Zhang H, Cao X, Feng B . Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design. Microbiol Spectr. 2022; 10(3):e0058622. PMC: 9241819. DOI: 10.1128/spectrum.00586-22. View

Wolf Y, Anderson A, Kuchroo V . TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2019; 20(3):173-185. PMC: 7327798. DOI: 10.1038/s41577-019-0224-6. View

Pehrson I, Sayyab S, Das J, Idh N, Paues J, Mendez-Aranda M . The spectrum of tuberculosis described as differential DNA methylation patterns in alveolar macrophages and alveolar T cells. Clin Epigenetics. 2022; 14(1):175. PMC: 9758029. DOI: 10.1186/s13148-022-01390-9. View

Khan N, Vidyarthi A, Amir M, Mushtaq K, Agrewala J . T-cell exhaustion in tuberculosis: pitfalls and prospects. Crit Rev Microbiol. 2016; 43(2):133-141. DOI: 10.1080/1040841X.2016.1185603. View

10.

Amini M, Hejazi M, Ghorban K, Mokhtarzadeh A, Baradaran B . Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer. Gene. 2020; 772:145376. DOI: 10.1016/j.gene.2020.145376. View

11.

Gevensleben H, Holmes E, Goltz D, Dietrich J, Sailer V, Ellinger J . PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy. Oncotarget. 2016; 7(48):79943-79955. PMC: 5346762. DOI: 10.18632/oncotarget.13161. View

12.

Amezquita R, Kaech S . Immunology: The chronicles of T-cell exhaustion. Nature. 2017; 543(7644):190-191. DOI: 10.1038/nature21508. View

13.

Feil R, Charlton J, Bird A, Walter J, Reik W . Methylation analysis on individual chromosomes: improved protocol for bisulphite genomic sequencing. Nucleic Acids Res. 1994; 22(4):695-6. PMC: 307863. DOI: 10.1093/nar/22.4.695. View

14.

Goltz D, Gevensleben H, Grunen S, Dietrich J, Kristiansen G, Landsberg J . PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia. Leukemia. 2016; 31(3):738-743. DOI: 10.1038/leu.2016.328. View

15.

Zhang Y, Xiang C, Wang Y, Duan Y, Liu C, Zhang Y . PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance. Oncotarget. 2017; 8(60):101535-101544. PMC: 5731894. DOI: 10.18632/oncotarget.21328. View

16.

Mu L, Long Y, Yang C, Jin L, Tao H, Ge H . The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas. Front Mol Neurosci. 2018; 11:82. PMC: 5882817. DOI: 10.3389/fnmol.2018.00082. View

17.

Pan S, Shu C, Huang J, Lee C, Tseng Y, Hung J . PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis. Int J Mol Sci. 2022; 23(3). PMC: 8836118. DOI: 10.3390/ijms23031619. View

18.

Saharia K, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P . Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS One. 2016; 11(7):e0158262. PMC: 4930205. DOI: 10.1371/journal.pone.0158262. View

19.

Goltz D, Gevensleben H, Dietrich J, Dietrich D . () promoter methylation predicts survival in colorectal cancer patients. Oncoimmunology. 2017; 6(1):e1257454. PMC: 5283627. DOI: 10.1080/2162402X.2016.1257454. View

20.

Wrangle J, Wang W, Koch A, Easwaran H, Mohammad H, Vendetti F . Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. Oncotarget. 2013; 4(11):2067-79. PMC: 3875770. DOI: 10.18632/oncotarget.1542. View